BrainsWay Ltd. (BWAY) Valuation — DCF, Graham & Comparables

BrainsWay Ltd. (BWAY) — Price $13.46 HealthcareMedical - Specialties — NASDAQ

Latest reported results:

Valuation dashboard for BrainsWay Ltd. (BWAY) with P/E 54.41, P/B 6.67, EV/EBITDA 73.40 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.

BrainsWay Ltd. develops and distributes non-invasive neurostimulation therapies that address a broad spectrum of mental health and neurological conditions. The company operates globally, with a presence in the United States, Europe, and Israel, among other international markets.

Analysis Summary

BrainsWay Ltd. reported revenue of $52.2M in the most recent fiscal year, growing at a 5-year CAGR of 18.8%.

Trailing-twelve-month margins: gross margin 75.3%, operating margin 12.2%, net margin 14.6%.

At the current price of $13.46, BWAY trades at a P/E of 54.41 and an ROE of 12.69%. Market capitalisation stands at $528M.

Balance sheet quality for BWAY: current ratio of 3.8. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.

Valuation Ratios

P/E Ratio54.41
Price / Book6.67
EV / EBITDA73.40
Dividend Yield0.00%

Valuation Models

DCF Fair Value$-12.14
vs Current Price-190.2%

Peer Comparison

SymbolCompanyMarket CapP/EP/BROE
BWAYBrainsWay Ltd.$528M54.416.6712.7%
ALCAlcon Inc.$32.2B51.851.52
0A0D.LAlcon Inc.$27.1B
STESTERIS plc$20.5B
0JZ2.LMasimo Corporation$9.5B9.69-21.0%
0QLQ.LYpsomed Holding AG$4.8B
0A05.LMedacta Group S.A.$2.3B

Price

Price$13.46
Market Cap$528M
ExchangeNASDAQ
CountryIL

Profitability

Return on Equity12.69%
Return on Invested Capital7.71%
Return on Assets7.76%
Gross Margin75.33%
Operating Margin12.18%
Net Margin14.61%

Related companies: CERS · CVRX · DCTH · MASS · NPCE · RXST · SENS

Explore sector: Healthcare · Medical - Specialties

More sections of BWAY: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks